S&P 500 Industrials Sector SEC Filings — February 16, 2026

17-02-2026

17-02-2026

Elite Pharmaceuticals Inc. /NV/ filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-007190), disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing typical for earnings releases, but no specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided information. Sector is not specified.

17-02-2026

Genuine Parts Co filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-053013), reporting results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases, with no positive or negative performance details available.

17-02-2026

Builders FirstSource, Inc. filed an 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, period-over-period changes, or other financial metrics are disclosed in the provided filing information. No positive or negative performance details, guidance, or comparisons are available.

17-02-2026

Global Business Travel Group, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001104659-26-015928, Size: 279 KB), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, or period-over-period comparisons are detailed in the filing information provided. This appears to be a standard earnings-related disclosure without quantified metrics.

17-02-2026

Rogers Corp filed a Form 8-K on 2026-02-17 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. This is a multi-item filing typical for earnings releases where specific quantitative metrics such as revenue, earnings, margins, or guidance are NOT_DISCLOSED in the provided information. No positive or negative performance indicators, period-over-period changes, or balance sheet effects are detailed.

17-02-2026

Republic Services, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001060391-26-000093), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, margins, guidance, or other quantitative metrics are provided in the filing description. No positive or negative performance indicators are available.

17-02-2026

Medalist Diversified REIT, Inc. filed an 8-K on 2026-02-17 (AccNo: 0001104659-26-016379) disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers creation of a direct financial obligation (Item 2.03), material modifications to rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific transaction parties, values, terms, financial metrics, synergies, or impacts are detailed.

• ·Accession Number: 0001104659-26-016379
• ·Filing size: 1 MB
• ·Sector: not specified

17-02-2026

Pitney Bowes Inc. filed an 8-K on February 17, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics were detailed in the provided filing information. The filing appears informational without directional financial indicators.

17-02-2026

The Hackett Group, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-054765), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item, voluntary disclosure typical for quarterly financial results announcements. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative metrics are disclosed in the provided filing details.

17-02-2026

17-02-2026

Honeywell International Inc filed a Form 8-K on February 17, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves a voluntary disclosure to comply with Regulation FD, with exhibits attached, but no specific financial metrics, transactions, or performance data are detailed. No positive or negative metrics are disclosed, providing only structural filing information.

17-02-2026

Portland General Electric Co /OR/ filed a Form 8-K on 2026-02-17 reporting multiple material items: entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing likely combining earnings release with new agreement and financing details. Specific transaction values, financial metrics, period-over-period changes, guidance, or impacts are NOT_DISCLOSED.

17-02-2026

Hyatt Hotels Corp filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names of individuals involved, appointment or resignation status, reasons for the change, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events were mentioned in the provided filing information.

17-02-2026

Sonoco Products Co filed an 8-K on February 17, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are detailed in the provided filing information. This represents a standard earnings-related disclosure without extracted numerical data.

17-02-2026

IDEAYA Biosciences, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-052741, Size: 344 KB), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or quantitative financial metrics are mentioned in the filing description. This is a standard financial results announcement with no disclosed positive or negative performance indicators.

17-02-2026

Matthews International Corp filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are disclosed.

17-02-2026

SPACSphere Acquisition Corp. filed an 8-K on 2026-02-17 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a merger/acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, or strategic rationale were explicitly stated. Sector not specified, limiting assessment of market implications.

• ·Accession Number: 0001829126-26-001360
• ·File Size: 467 KB

17-02-2026

Artificial Intelligence Technology Solutions Inc. filed an 8-K on February 17, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of any exhibits are provided. No quantitative metrics, positive or negative changes, or financial impacts are mentioned.

17-02-2026

AG Mortgage Investment Trust, Inc. filed a Form 8-K on February 17, 2026, reporting solely under Item 8.01 Other Events. No specific details on the nature of the event, financial metrics, transactions, or impacts are disclosed. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

17-02-2026

Neogenomics Inc filed an 8-K on February 17, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are mentioned. This is an informational earnings-related disclosure with no detailed performance data provided.

17-02-2026

Shutterstock, Inc. filed a Form 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or other quantitative metrics are provided in the filing description. No positive or negative performance indicators, period-over-period changes, or strategic details are mentioned.

17-02-2026

Science Applications International Corp filed an 8-K on 2026-02-17 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or market impacts are mentioned.

17-02-2026

Coronado Global Resources Inc. filed an 8-K on February 17, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the disclosure content, financial statements, exhibits, or any metrics are provided in the filing summary. This appears to be a voluntary disclosure of material information pursuant to Regulation FD.

17-02-2026

SunocoCorp LLC filed an 8-K on February 17, 2026, under Item 2.02 for Results of Operations and Financial Condition, Item 7.01 for Regulation FD Disclosure, and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the provided filing information. This is an informational earnings-related disclosure without quantified metrics.

17-02-2026

Sunoco LP filed an 8-K on February 17, 2026, disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are mentioned in the provided filing summary. This is a multi-item filing typical for earnings releases, but detailed quantitative data is NOT_DISCLOSED.

17-02-2026

SideChannel, Inc. filed an 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, vote outcomes, or quantitative data are disclosed in the provided filing information. This multi-item filing combines earnings-related disclosure with shareholder meeting results.

17-02-2026

M3-Brigade Acquisition V Corp. filed an 8-K on 2026-02-17 under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific merger/acquisition details, transaction values, parties involved, financial metrics, or period-over-period comparisons were explicitly stated in the filing information provided. Sector was not specified.

17-02-2026

Danaher Corp filed a Form 8-K on February 17, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the events, transactions, financial metrics, or exhibits are provided in the filing summary.

17-02-2026

Telomir Pharmaceuticals, Inc. filed an 8-K on February 17, 2026, reporting under Item 8.01 Other Events. No specific details, financial metrics, transactions, or other quantitative data are disclosed in the provided filing information. The filing has AccNo 0001493152-26-006937 and size 207 KB.

17-02-2026

Gemini Space Station, Inc. filed an 8-K on 2026-02-17 disclosing results of operations and financial condition under Item 2.02 and an officer or director change, including potential compensatory arrangements, under Item 5.02. No specific details such as the key position affected, appointment or resignation status, reasons for the change, board impacts, financial metrics, or quantitative data are provided. The filing is informational with no disclosed positive or negative performance indicators.

17-02-2026

Cogent Biosciences, Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-053131), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were mentioned. This is a standard financial results announcement without quantified metrics provided.

17-02-2026

CNS Pharmaceuticals, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001683168-26-001066), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, timing, or any compensatory arrangements are disclosed. No quantitative metrics, financial data, or performance comparisons are provided.

17-02-2026

Howmet Aerospace Inc. filed a Form 8-K on February 17, 2026 (AccNo: 0001104659-26-015914), reporting under Item 8.01 Other Events. No specific details regarding the nature of the other event, financial metrics, transactions, or scheduled events are disclosed in the provided filing information. Sector is not specified.

17-02-2026

Bowman Consulting Group Ltd. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, timing, or any quantitative financial metrics are disclosed. This appears to be a routine governance disclosure without additional performance data.

17-02-2026

Marriott Vacations Worldwide Corp filed an 8-K on February 17, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected officer's name, title, reason for departure or appointment, effective date, or internal/external status are disclosed. No quantitative financial metrics, performance comparisons, or governance impacts are provided in the available information.

17-02-2026

Otter Tail Corp filed a Form 8-K on February 17, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, or guidance metrics are disclosed in the provided filing information. All quantitative financial details are NOT_DISCLOSED.

17-02-2026

NRX Pharmaceuticals, Inc. filed an 8-K on February 17, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the filing summary provided.

17-02-2026

SAN JUAN BASIN ROYALTY TRUST filed an 8-K on February 17, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, distributions, period-over-period changes, or other quantitative financial metrics are mentioned in the provided filing details. This appears to be a standard informational filing for operational results with no disclosed directional impacts.

17-02-2026

Permian Basin Royalty Trust filed an 8-K on February 17, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing information.

17-02-2026

Mercury General Corp filed an 8-K on February 17, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or guidance details are disclosed in the filing information provided. This is an informational disclosure typical for quarterly or annual earnings releases.

17-02-2026

Quantum Corp /DE/ filed an 8-K on February 17, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard voluntary earnings-related disclosure with no detailed performance data available.

• ·AccNo: 0001628280-26-008553
• ·File size: 473 KB
• ·Event Type: Financial Results
• ·Source: us_sec

17-02-2026

RB Global Inc. filed a Form 8-K on February 17, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing details. This multi-item filing is typical for earnings releases but lacks quantitative metrics or performance indicators.

17-02-2026

Cadence Design Systems Inc filed an 8-K on February 17, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative data are disclosed in the provided filing summary. This appears to be a standard mandatory earnings-related disclosure with attached financial statements.

17-02-2026

Armour Residential REIT, Inc. filed an 8-K on February 17, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, financial metrics, transactions, or exhibits are disclosed in the provided filing summary. This is a multi-item voluntary disclosure with no quantitative data or directional impacts mentioned.

17-02-2026

Safe & Green Development Corp filed a Form 8-K on February 17, 2026, disclosing entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This multi-item filing signals a significant transaction involving financing or partnership activity, but no specific dollar values, share counts, or financial impacts are disclosed. No positive or negative metrics are provided, resulting in no directional bias.

17-02-2026

TRUSTCO BANK CORP N Y filed an 8-K on February 17, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Specific details of the other events and the financial statements or exhibits are NOT_DISCLOSED. No quantitative metrics, transactions, or strategic implications are provided in the filing summary.

17-02-2026

Quad/Graphics, Inc. filed an 8-K on 2026-02-17 disclosing changes related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative data are disclosed in the provided filing summary.

17-02-2026

ImageneBio, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054684), disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, effective dates, or financial details such as compensation amounts are disclosed in the provided information. No quantitative metrics, performance comparisons, or additional context provided.

17-02-2026

Devon Energy Corp filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054657), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics were disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure with exhibits attached.

• ·Filing size: 860 KB
• ·Source: US SEC
• ·Sector: not specified

17-02-2026

Advanced Micro Devices Inc. filed an 8-K on February 17, 2026 (AccNo: 0000002488-26-000029), disclosing information under Item 5.02 regarding departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are disclosed. This is a routine SEC-required disclosure for leadership changes with no additional quantitative or qualitative context provided.

17-02-2026

Andersons, Inc. filed an 8-K on February 17, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or other quantitative financial metrics were disclosed in the provided filing details. This is a standard disclosure for financial results with no mentioned positive or negative performance indicators.

17-02-2026

Hecla Mining Co/DE/ filed an 8-K on February 17, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details. Analysis is constrained by absence of detailed financial data.

17-02-2026

Apimeds Pharmaceuticals US, Inc. filed an 8-K on 2026-02-17 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing includes financial statements and exhibits under Item 9.01. No specific transaction details, parties, values, or financial impacts are disclosed.

17-02-2026

DeFi Development Corp. filed an 8-K on February 17, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific details on the disclosed information, financial metrics, transactions, or exhibits are provided in the filing summary. This appears to be a voluntary informational disclosure with no quantified positive or negative impacts mentioned.

17-02-2026

Mereo BioPharma Group plc filed a Form 8-K on 2026-02-17 under Item 3.01 announcing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing from the US market. No quantitative financial metrics, transaction values, or additional details such as revenue impacts, balance sheet effects, or guidance changes were disclosed.

17-02-2026

GREAT SOUTHERN BANCORP, INC. filed a Form 8-K on February 17, 2026 (AccNo: 0001171843-26-000861, size: 218 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed. This appears to be a multi-item informational filing with no quantified metrics or directional impacts provided.

17-02-2026

Equity Bancshares Inc filed a Form 8-K on 2026-02-17 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), with Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of a material event involving a new agreement and financial obligation. No quantitative details, transaction values, parties, impacts, or performance metrics (positive, negative, or flat) are disclosed.

• ·AccNo: 0001193125-26-054930
• ·File Size: 298 KB

17-02-2026

Falcon's Beyond Global, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the officer, position affected, reason for change, or any quantitative impacts are NOT_DISCLOSED.

17-02-2026

FingerMotion, Inc. filed an 8-K on February 17, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, positive or negative changes, or quantitative data are disclosed in the provided filing information.

17-02-2026

Civista Bancshares, Inc. filed a Form 8-K on February 17, 2026, reporting under Item 5.08 regarding shareholder nominations pursuant to Exchange Act Rule 14a-11 and under Item 8.01 other events. No quantitative financial metrics, transaction values, or performance comparisons were disclosed. This is a multi-item procedural filing with no indicated positive or negative impacts.

17-02-2026

Andretti Acquisition Corp. II filed an 8-K on 2026-02-17 disclosing the termination of a material definitive agreement under Item 1.02. The filing also references financial statements and exhibits under Item 9.01. No specific details on the agreement parties, terms, financial impacts, or other metrics are provided.

17-02-2026

Bayview Acquisition Corp filed an 8-K on 2026-02-17 under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No quantitative financial metrics, deal structure details, parties involved, or merger/acquisition specifics are disclosed in the filing summary. Sector is not specified.

17-02-2026

Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-007204), reporting under Item 2.02 for Results of Operations and Financial Condition. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were disclosed in the provided filing information. This appears to be a single-item, mandatory disclosure typical for financial results announcements.

17-02-2026

GENCO SHIPPING & TRADING LTD filed a Form 8-K on February 17, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are mentioned in the provided filing information. This is a voluntary disclosure of financial results with no extracted positive or negative performance indicators.

17-02-2026

DIRTT Environmental Solutions Ltd filed a Form 8-K on February 17, 2026 (AccNo: 0001193125-26-055157), reporting entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, and Regulation FD disclosure under Item 7.01. This is a multi-item filing with no specific transaction details, financial metrics, dollar values, or named individuals disclosed. No positive or negative performance metrics were provided, preventing assessment of directional impact.

17-02-2026

GeoVax Labs, Inc. filed an 8-K on February 17, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02. Regulation FD disclosure is provided under Item 7.01, accompanied by financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period metrics are disclosed.

17-02-2026

Bally's Corp filed an 8-K on February 17, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, transaction terms, dollar values, or financial impacts are disclosed.